Canada markets closed
  • S&P/TSX

    21,216.15
    +3.76 (+0.02%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • DOW

    35,677.02
    +73.94 (+0.21%)
     
  • CAD/USD

    0.8091
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    83.98
    +1.48 (+1.79%)
     
  • BTC-CAD

    75,613.27
    -1,095.47 (-1.43%)
     
  • CMC Crypto 200

    1,453.34
    -49.69 (-3.31%)
     
  • GOLD FUTURES

    1,793.10
    +11.20 (+0.63%)
     
  • RUSSELL 2000

    2,291.27
    -4.92 (-0.21%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • NASDAQ

    15,090.20
    -125.50 (-0.82%)
     
  • VOLATILITY

    15.43
    +0.42 (+2.80%)
     
  • FTSE

    7,204.55
    +14.25 (+0.20%)
     
  • NIKKEI 225

    28,804.85
    +96.27 (+0.34%)
     
  • CAD/EUR

    0.6942
    -0.0010 (-0.14%)
     

Meerut: Over 2 lakh people due for second dose of COVID-19 vaccine, says Chief Medical Officer

·1 min read
Meerut Chief Medical Officer Akhilesh Mohan (Photo/ANI)
Meerut Chief Medical Officer Akhilesh Mohan (Photo/ANI)

Meerut (Uttar Pradesh) [India], September 22 (ANI): Over 2 lakh people have not taken their second dose COVID-19 vaccination in Meerut, said Chief Medical Officer Akhilesh Mohan.

"More than 2 lakh people are due to take their second COVID-19 vaccine dose," he told ANI on Tuesday.

Reiterating the need to pace up the vaccination coverage in the city, the Chief Medical Officer urged people to come forward and take their second dose of the vaccine.

"We have done good work in administering the first dose of COVID-19 vaccine. People are having indifferent attitudes towards taking their second jab. I urge people, who are due to take their second dose, to go to vaccination centres and get inoculated," said Mohan.

He further said, "The government has directed to administer only second dose on Saturday because our pending doses to eligible beneficiaries of the second dose are increasing."

Meanwhile, India's COVID-19 vaccination coverage crossed 82 crores on Tuesday. (ANI)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting